Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

  1. Client, organization or corporation number: 371
Share this search Create an alert

Refine registrations results by

Refine monthly communication reports results by

Type Subject matter of the communication
Government institution of the DPOH

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Monthly communication reports (916)
Results: 1-50 | Export
  1. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-04-15
    Posted: 2024-05-14
    Designated public office holders:
    • Mark Schaan, Senior Assistant Deputy Minister, Strategy and Innovation Policy Sector - Assistant Deputy Minister's Office | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Federal-Provincial Relations
    • Industry
    • International Trade
    • Science and Technology
    • Health
    • Intellectual Property
    • Foreign Affairs
    • Taxation and Finance
    • Research and Development
    • Infrastructure
    • Small Business
  2. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-04-15
    Posted: 2024-05-14
    Designated public office holders:
    • Brian Masse, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Science and Technology
    • International Trade
    • Foreign Affairs
    • Taxation and Finance
    • Research and Development
    • Small Business
    • Infrastructure
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-04-15
    Posted: 2024-05-14
    Designated public office holders:
    • Étienne-René Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Francis Bilodeau, Associate Deputy Minister, Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • International Trade
    • Small Business
    • Intellectual Property
    • Research and Development
    • Taxation and Finance
    • Foreign Affairs
    • Infrastructure
    • Health
    • Federal-Provincial Relations
    • Industry
    • Science and Technology
  4. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-03-01
    Posted: 2024-04-12
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
  5. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-18
    Posted: 2024-02-12
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  6. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-11
    Posted: 2024-02-12
    Designated public office holders:
    • Michelle Boudreau, Associate Assistant Deputy Minister of Health | Health Canada (HC)
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  7. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2024-01-05
    Posted: 2024-02-12
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
  8. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
    • Stephen Lucas, Deputy Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
  9. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Jennifer Miller , Assistant Secretary | Privy Council Office (PCO)
    Subject matters:
    • Health
  10. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-12
    Posted: 2024-01-15
    Designated public office holders:
    • Jean-Sebastien Bock, Deputy Chief of Staff, Office of the Minister of Health | Health Canada (HC)
    • Ehsan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
  11. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-12-08
    Posted: 2024-01-15
    Designated public office holders:
    • Ehsan Naik , Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
  12. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Gigi Osler, Senator | Senate of Canada
    Subject matters:
    • Health
    • Industry
  13. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Mohamed-Iqbal Ravalia, Senator | Senate of Canada
    • Sarah Polowin, Director of Parliamentary Affairs | Senate of Canada
    Subject matters:
    • Health
    • Industry
  14. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Sébastien Lemire, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
  15. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-08
    Posted: 2023-12-08
    Designated public office holders:
    • Ritu Banerjee, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Science and Technology
    • Health
    • Industry
  16. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Helena Jaczek, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Science and Technology
    • Industry
  17. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Robert Kitchen, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
    • Science and Technology
  18. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Luc Thériault, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  19. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Marie-Françoise Mégie, Senator | Senate of Canada
    Subject matters:
    • Health
    • Industry
  20. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Jessica LaForge, Policy Advisor | Pacific Economic Development Canada (PacifiCan)
    • Gurjiven Sandhu, Director of Policy | Pacific Economic Development Canada (PacifiCan)
    Subject matters:
    • Health
    • Science and Technology
    • Regional Development
  21. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Sharon Burey, Senator | Senate of Canada
    Subject matters:
    • Health
  22. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Jennifer Miller , Assistant Secretary | Privy Council Office (PCO)
    • Alexis Conrad, Assistant Secretary to the Cabinet | Privy Council Office (PCO)
    • Jeff Warning, Associate Assistant Secretary | Privy Council Office (PCO)
    Subject matters:
    • Health
    • Industry
  23. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Francis Scarpaleggia, Member of Parliament | House of Commons
    Subject matters:
    • Health
  24. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Rechie Valdez, Member of Parliament and Minister of Small Business | House of Commons
    • Chris Zhou, Senior Policy and Atlantic Advisor, Office of the Minister of Small Business | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Small Business
    • Health
    • Industry
  25. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Ehsan Naik , Director of Policy, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
  26. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • James Hawkes, Parliamentary Assistant | House of Commons
    • Corey Tochor, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
  27. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-07
    Posted: 2023-12-08
    Designated public office holders:
    • Christopher Evelyn, Chief of Staff to the Minister of Families, Children & Social Development | Employment and Social Development Canada (ESDC)
    • Layla Platt, Executive Assistant | Employment and Social Development Canada (ESDC)
    Subject matters:
    • Industry
    • Health
    • Small Business
    • Science and Technology
  28. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Pamela Aung-Thin , Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    • Dr. Stephen Lucas, Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  29. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Suzy McDonald, Associate Deputy Minister | Finance Canada (FIN)
    Subject matters:
    • Health
    • Science and Technology
    • Industry
  30. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Carol Hughes, Member of Parliament | House of Commons
    Subject matters:
    • Industry
    • Health
  31. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Chandra Arya, Member of the House of Commons | House of Commons
    Subject matters:
    • Health
  32. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Josh Dadjo, Director of Parliamentary Affairs | Senate of Canada
    Subject matters:
    • Industry
    • Health
    • Science and Technology
  33. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Andrew Cardozo, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
  34. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Francesco Sorbara, Member of Parliament | House of Commons
    Subject matters:
    • Health
    • Industry
  35. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Valerie Bradford, Member of Parliament | House of Commons
    Subject matters:
    • Health
  36. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
  37. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Health
  38. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Stan Kutcher, Senator | Senate of Canada
    Subject matters:
    • Industry
    • Health
  39. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-06
    Posted: 2023-12-08
    Designated public office holders:
    • Ben Chin, Senior Advisor | Prime Minister's Office (PMO)
    Subject matters:
    • Science and Technology
    • Industry
    • Health
  40. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-11-01
    Posted: 2023-12-08
    Designated public office holders:
    • Eshan Naik, Director of Policy, Office of the Minister of Health | Health Canada (HC)
    • Ophelia John , Senior Policy Advisor, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
  41. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-10-05
    Posted: 2023-11-10
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  42. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-10-04
    Posted: 2023-11-10
    Designated public office holders:
    • Ophelia John, Senior Policy Advisor, Office of the Minister of Health | Health Canada (HC)
    • Mark Holland, Minister of Health | Health Canada (HC)
    • Jean Sebastien Bock, Deputy Chief of Staff, Office of the Minister of Health | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  43. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-09-21
    Posted: 2023-10-11
    Designated public office holders:
    • Dr. Stephen Ellis, Member of Parliament | House of Commons
    Subject matters:
    • Health
  44. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-09-14
    Posted: 2023-10-11
    Designated public office holders:
    • Pamela Aung-Thin, Assistant Deputy Minister, Health Products and Food Branch | Health Canada (HC)
    Subject matters:
    • Industry
    • Health
  45. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-08-23
    Posted: 2023-09-14
    Designated public office holders:
    • Nancy Hamzawi, Executive Vice-President | Public Health Agency of Canada (PHAC)
    Subject matters:
    • Industry
    • Health
  46. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-08-23
    Posted: 2023-09-14
    Designated public office holders:
    • Simon Kennedy , Deputy Minister, Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
    Subject matters:
    • Industry
    • Health
  47. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-08-10
    Posted: 2023-09-14
    Designated public office holders:
    • Yash Nanda, Policy Advisor | Finance Canada (FIN)
    Subject matters:
    • Taxation and Finance
    • Health
  48. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-08-02
    Posted: 2023-09-14
    Designated public office holders:
    • Susan Fitzpatrick, CEO, Canadian Drug Agency Transition Office | Health Canada (HC)
    Subject matters:
    • Health
  49. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-08-01
    Posted: 2023-09-14
    Designated public office holders:
    • Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
    Subject matters:
    • Health
    • Industry
  50. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-07-21
    Posted: 2023-08-01
    Designated public office holders:
    • Thomas Digby, Chairperson | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Intellectual Property
    • Industry

Date Modified: